Search

Your search keyword '"Lenting, Peter J."' showing total 22 results

Search Constraints

Start Over You searched for: Author "Lenting, Peter J." Remove constraint Author: "Lenting, Peter J." Topic factor viii Remove constraint Topic: factor viii
22 results on '"Lenting, Peter J."'

Search Results

1. Genotype-Dependent Response to Desmopressin in Hemophilia A and Proposal of a Predictive Response Score.

2. Differences in venous clot structures between hemophilic mice treated with emicizumab versus factor VIII or factor VIIIFc.

3. von Willebrand disease: what does the future hold?

4. Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19.

5. A factor VIII-nanobody fusion protein forming an ultrastable complex with VWF: effect on clearance and antibody formation.

6. Emerging Therapeutic Strategies in the Treatment of Hemophilia A.

7. Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.

8. Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant.

9. Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5.

10. Cleavage of von Willebrand factor by granzyme M destroys its factor VIII binding capacity.

11. Models for prediction of factor VIII half-life in severe haemophiliacs: distinct approaches for blood group O and non-O patients.

12. Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo.

13. Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13.

14. Functional duplication of ligand-binding domains within low-density lipoprotein receptor-related protein for interaction with receptor associated protein, alpha2-macroglobulin, factor IXa and factor VIII.

15. VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors.

16. Factor VIII half-life and clinical phenotype of severe hemophilia A.

17. Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency.

18. Low density lipoprotein receptor-related protein and factor IXa share structural requirements for binding to the A3 domain of coagulation factor VIII.

19. Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNA

20. Aspects fonctionnels et cliniques de l'emicizumab, un anticorps bispécifique utilisé dans le traitement de l'hémophilie A.

21. Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa.

22. Functional duplication of ligand-binding domains within low-density lipoprotein receptor-related protein for interaction with receptor associated protein, α2-macroglobulin, factor IXa and factor VIII

Catalog

Books, media, physical & digital resources